{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:09:18Z","timestamp":1789193358592,"version":"build-2803163510"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson & Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP Rep"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Objective Maternal red cell alloimmunization is a rare pregnancy condition that can cause hemolytic disease of the fetus and newborn (HDFN), which can be serious and fatal. As subsequent alloimmunized pregnancies carry HDFN risk, families\u2019 future pregnancy decisions may be affected. Findings from qualitative interviews in alloimmunized mothers are presented to understand experiences and perspectives during their previous pregnancy affected by severe HDFN, aiming to inform patient-centered interventions.<\/jats:p>\n                  <jats:p>Study Design This article presents qualitative findings of a broader mixed-methods study published elsewhere. Semi-structured 1:1 interviews were conducted via Microsoft Teams with adults (\u226518 years) who experienced a pregnancy within the past 5 years affected by severe HDFN (i.e., intrauterine transfusion, fetal loss after 14 weeks\u2019 gestation, or neonatal death within 4 weeks of birth due to HDFN). A patient advocacy group ensured study design\u2019s relevance, recruited participants, and helped interpret results. Interviews were audio-recorded, transcribed, and analyzed to identify key themes.<\/jats:p>\n                  <jats:p>Results Of 28 participants, 27 completed interviews. Participants reported a median 2 (range, 1\u20135) affected HDFN pregnancies and a median 4 (1\u201311) intrauterine transfusions during their most recent pregnancy affected by severe HDFN. Seven themes were identified: (1) diagnosis communication and information seeking, (2) emotional journey at diagnosis, (3) navigating the treatment regimen, (4) physical\/emotional challenges during pregnancy, (5) impacts on social life, (6) experience at delivery, and (7) postdelivery adjustment and reflections. Results indicated that participants felt inadequately informed about their diagnosis, experienced significant emotional distress, along with difficulties managing intense monitoring\/treatments. Many described their delivery as traumatic and their postpartum as very stressful, which influenced their decision about additional pregnancies.<\/jats:p>\n                  <jats:p>Conclusion These findings highlight opportunities to strengthen communication and support for pregnant individuals experiencing severe HDFN. Developing comprehensive support models and improving care, guided by patient preferences, could address the needs of affected individuals and families.<\/jats:p>","DOI":"10.1055\/a-2948-6478","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:22:10Z","timestamp":1788996130000},"page":"e171-e178","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Patient Perspectives and Experiences in Severe Hemolytic Disease of the Fetus and Newborn: Insights from Qualitative Interviews"],"prefix":"10.1055","volume":"16","author":[{"given":"Adele","family":"Barlassina","sequence":"additional","affiliation":[{"name":"OPEN Health HEOR and Market Access, United Kingdom of Great Britain and Northern Ireland","place":["Marlow"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6634-2193","authenticated-orcid":false,"given":"Molly","family":"Sherwood","sequence":"additional","affiliation":[{"name":"Allo Hope Foundation, Alabama, United States","place":["Tuscaloosa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4953-0472","authenticated-orcid":false,"given":"Divya","family":"Mohan","sequence":"additional","affiliation":[{"name":"OPEN Health HEOR and Market Access, United Kingdom of Great Britain and Northern Ireland","place":["Marlow"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Boeri","sequence":"additional","affiliation":[{"name":"OPEN Health HEOR and Market Access, United Kingdom of Great Britain and Northern Ireland","place":["Marlow"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Janssen","sequence":"additional","affiliation":[{"name":"Johnson & Johnson, New Jersey, United States","place":["Titusville"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Krumme","sequence":"additional","affiliation":[{"name":"Johnson & Johnson, New Jersey, United States","place":["Titusville"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-6521","authenticated-orcid":false,"given":"Laura M.","family":"Bozzi","sequence":"additional","affiliation":[{"name":"Johnson & Johnson, New Jersey, United States","place":["Raritan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"M de Haas","year":"2015","journal-title":"Vox Sang"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM). Society for Maternal-Fetal Medicine (SMFM) clinical guideline #8: the fetus at risk for anemia\u2014diagnosis and management","volume":"212","author":"G Mari","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12884-025-07208-9","article-title":"Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review","volume":"25","author":"P Maurice","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00431-022-04724-0","article-title":"History and current standard of postnatal management in hemolytic disease of the fetus and newborn","volume":"182","author":"D P De Winter","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1471-0528.12063","article-title":"Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation","volume":"120","author":"I T Lindenburg","year":"2013","journal-title":"BJOG"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures","volume":"50","author":"C Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000328683","article-title":"Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm","volume":"30","author":"E Tiblad","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"ref8","volume-title":"Hemolytic disease of the newborn","author":"L Dean","year":"2005"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ajog.2024.03.044","article-title":"Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis","volume":"231","author":"H J Mustafa","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17474086.2017.1331124","article-title":"Neonatal management and outcome in alloimmune hemolytic disease","volume":"10","author":"I MC Ree","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"K J Moise Jr","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.xagr.2023.100203","article-title":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","volume":"3","author":"D Yu","year":"2023","journal-title":"AJOG Glob Rep"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1055\/a-2690-9547","article-title":"Alloimmunization in pregnancy: patient-reported quality of care, mental health effects, and impact upon daily life","volume":"15","author":"M R Sherwood","year":"2025","journal-title":"AJP Rep"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1475-6773.2006.00684.x","article-title":"Qualitative data analysis for health services research: developing taxonomy, themes, and theory","volume":"42","author":"E H Bradley","year":"2007","journal-title":"Health Serv Res"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/14413582241264619","article-title":"What is qualitative research? An overview and guidelines","volume":"33","author":"W M Lim","year":"2024","journal-title":"Australas Mark J"},{"issue":"08","key":"ref16","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1371\/journal.pmed.0040258","article-title":"Qualitative research: understanding patients\u2019 needs and experiences","volume":"4","author":"PLoS Medicine Editors","year":"2007","journal-title":"PLoS Med"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"S311","DOI":"10.1016\/j.jval.2025.04.1335","article-title":"PCR12 hemolytic disease of the fetus and newborn (HDFN): A mixed-methods preference study","volume":"28","author":"D Mohan","year":"2025","journal-title":"Value Health"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"V Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/15586898221126816","article-title":"Inductive\/deductive hybrid thematic analysis in mixed methods research","volume":"17","author":"K Proudfoot","year":"2023","journal-title":"J Mixed Methods Res"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"S563","DOI":"10.1016\/j.jval.2024.10.3528","article-title":"PCR286 targeted literature review to explore the patient experience of hemolytic disease of the foetus and newborn (HDFN)","volume":"27","author":"J Barthelmes","year":"2024","journal-title":"Value Health"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"e2454342","DOI":"10.1001\/jamanetworkopen.2024.54342","article-title":"Hemolytic disease of the fetus and newborn-a need for management consensus and more worldwide representation","volume":"8","author":"T M Slusher","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"09","key":"ref22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/trf.17967","article-title":"A review of attitudes to urgent RhD-positive transfusions in female patients and the risk for hemolytic disease of the fetus and newborn","volume":"64","author":"M H Yazer","year":"2024","journal-title":"Transfusion"},{"key":"ref23","first-page":"42","article-title":"PA06\u2013L04 development of evidence-based guidelines for emergency resuscitation of females of childbearing potential and risk mitigation of hemolytic disease of the fetus and newborn","volume":"120","author":"M R Sherwood","year":"2025","journal-title":"Vox Sang"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"e2544649","DOI":"10.1001\/jamanetworkopen.2025.44649","article-title":"A clinical practice guideline for the management of pregnancy alloimmunized to red blood cell antigens","volume":"8","author":"K J Moise Jr","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/heq.2023.0191","article-title":"Reviewing models of patient advocacy: current successes and future directions for applying community health workers and patient advocates to advance health equity","volume":"8","author":"A Simkus","year":"2024","journal-title":"Health Equity"}],"container-title":["American Journal of Perinatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2948-6478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:21:45Z","timestamp":1789190505000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2948-6478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2026,7,31]]},"published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2948-6478","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2157-6998","2157-7005"],"issn-type":[{"value":"2157-6998","type":"print"},{"value":"2157-7005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}